-
1 month ago | 
eprints.gla.ac.uk | De Boer |Anna Maria |John J.V
Docherty, K. F. et al. (2025) Interleukin-6 in heart failure with reduced ejection fraction and the effect of dapagliflozin : an exploratory analysis of the dapagliflozin and prevention of adverse outcomes in heart failure trial. JACC: Heart Failure, (doi: 10.1016/j.jchf.2024.12.012) (PMID:40088234) (In Press)Text350177.pdf - Published Version Available under License Creative Commons Attribution.
-
Jan 10, 2025 | 
eprints.gla.ac.uk | John J.V |Matthew M.Y
Osmanska, J. et al. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF). European Journal of Heart Failure, (doi: 10.1002/ejhf.3570) (PMID:39792133) (Early Online Publication)Text343617.pdf - Published Version Available under License Creative Commons Attribution.
-
Dec 18, 2024 | 
eprints.gla.ac.uk | van der Meer |De Pasquale |John J.V
Amir, O. et al. (2025) Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE ‐ MI trial data. European Journal of Heart Failure, (doi: 10.1002/ejhf.3542) (PMID:39692068) (Early Online Publication)Text343749.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives.
-
Nov 25, 2024 | 
eprints.gla.ac.uk | John J.V |Katriona J.M |M. Mitchell |Matthew M.Y
Docherty, K. F. et al. (2024) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, (Accepted for Publication)Text343035.pdf - Accepted Version Restricted to Repository staff only386kBAbstractNo abstract available.
-
Nov 8, 2024 | 
eprints.gla.ac.uk | Matthew M.Y |John J.V
Osmanska, J., Petrie, M. C. , Docherty, K. F. , Lee, M. M.Y. , McMurray, J. J.V. and Campbell, R. (2024) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae083) (Accepted for Publication)Text340966.pdf - Accepted Version Available under License Creative Commons Attribution.
-
Oct 22, 2024 | 
eprints.gla.ac.uk | John J.V
Lu, H. et al. (2024) Visit‐to‐visit changes in heart rate in heart failure: A pooled participant‐level analysis of the PARADIGM‐HF and PARAGON‐HF trials. European Journal of Heart Failure, (doi: 10.1002/ejhf.3487) (PMID:39439294) (Early Online Publication)Full text not currently available from Enlighten.
-
Sep 30, 2024 | 
eprints.gla.ac.uk | John J.V |Carolyn S.P |Hiddo J.L
Butt, J. H. et al. (2024) Therapeutic effects of heart failure medical therapies on standardized kidney outcomes: Comprehensive individual participant-level analysis of 6 randomized clinical trials. Circulation, (doi: 10.1161/circulationaha.124.071110) (PMID:39217458) (Accepted for Publication)Text334738.pdf - Accepted Version Restricted to Repository staff only until 30 March 2025.
-
Sep 24, 2024 | 
eprints.gla.ac.uk | John J.V
Wang, X. et al. (2024) Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE‐MI echocardiographic substudy. European Journal of Heart Failure, (doi: 10.1002/ejhf.3472) (PMID:39315586) (Early Online Publication)Full text not currently available from Enlighten. AbstractAims:The incidence of heart failure hospitalization is higher in women than in men after myocardial infarction (MI).
-
Sep 19, 2024 | 
eprints.gla.ac.uk | De Boer |Carolyn S.P |John J.V
Pabon, M. A. et al. (2024) In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.3410) (PMID:39300780) (Early Online Publication)Text336363.pdf - Published Version Available under License Creative Commons Attribution Non-commercial.
-
Sep 11, 2024 | 
eprints.gla.ac.uk | John J.V
Butt, J. H., Shen, L., Inzucchi, S. E., Docherty, K. F. , Jhund, P. S. , Martinez, F. A., Sabatine, M. S., Vaduganathan, M., Solomon, S. D. and McMurray, J. J.V. (2024) Dapagliflozin in heart failure, type 2 diabetes, and neuropathy. JACC: Heart Failure, 12(11), pp. 1946-1948. (doi: 10.1016/j.jchf.2024.07.017) (PMID:39269393) Full text not currently available from Enlighten. AbstractNo abstract available.
